Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Sex Differences: Potential Impact in Vascular Physiopathology or Ischemic Heart Disease

Kingma Jr, J.G.·2022·Cardiology & Vascular Research
DOI 10.33425/2639-8486.1134
Open this paper in CoChat — free account

Abstract

Pathophysiological mechanisms for development and progression of ischemic heart disease, which is essentially an age-related condition, may differ between men and women. Age-related changes in cardiac and vascular anatomy and physiopathology combined with traditional risk factors affect the likelihood of developing heart disease. Sex specific features of cardiac and vascular remodeling with age are associated with a higher prevalence of ischemic heart disease in women post-menopause. Cardiac symptoms such as chest pain/discomfort are often less in women, which generally results in less aggressive clinical treatment compared to men. Incidentally, treatment guidelines for acute myocardial infarction have for the most part, been established from studies with a large male cohort. Sex differences relating to effects of ischemia on overall cardiovascular function could contribute to worse clinical outcomes for females. Treatment options for women also arise because they generally present with multiple co-morbidities. The present review focuses on recent findings for sex differences in pathogenesis of ischemic heart disease, vascular function as well as potential use of cardio protection strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.33425/2639-8486.1134

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Part of this paper’s reference list could not be split into single entries.

Show all 2 references

Research works printed but not linked: 99

  1. Pepine CJ, Ferdinand KC, Shaw LJ, et al. Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography. J Am Coll Cardiol. 2015; 66: 1918-1933.
  2. Mehta LS, Beckie TM, DeVon HA, et al. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation. 2016; 133: 916-947.
  3. Wilmot KA, O'Flaherty M, Capewell S, et al. Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women. Circulation. 2015; 132: 997-1002.
  4. Groepenhoff F, Bots SH, Kessler EL, et al. Sex-Specific Aspects in the Pathophysiology and Imaging of Coronary Macro and Microvascular Disease. J Cardiovasc Transl Res. 2020; 13: 39- 46.
  5. Parvand M, Rayner-Hartley E, Sedlak T. Recent Developments in Sex-Related Differences in Presentation, Prognosis, and Management of Coronary Artery Disease. Can J Cardiol. 2018; 34: 390-399.
  6. Reis SE, Holubkov R, Conrad Smith AJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001; 141: 735-741.
  7. Jespersen L, Hvelplund A, Abildstrom SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012; 33: 734-744.
  8. Vaccarino V, Krumholz HM, Berkman LF, et al. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women?. Circulation. 1995; 91: 1861-1871.
  9. Bucholz EM, Butala NM, Rathore SS, et al. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014; 130: 757-767.
  10. Censin JC, Peters SAE, Bovijn J, et al. Causal relationships between obesity and the leading causes of death in women and men. PLoS Genet. 2019; 15: e1008405.
  11. Russo G, Rea F, Barbati G, et al. Sex-related differences in chronic heart failure: a community-based study. J Cardiovasc Med. 2021; 22: 36-44.
  12. Isensee J, Witt H, Pregla R, et al. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med (Berl). 2008; 86: 61-74.
  13. Queiros AM, Eschen C, Fliegner D, et al. Sex-and estrogen- dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol. 2013; 169: 331-338.
  14. Cheng S, Fernandes VR, Bluemke DA, et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2009; 2: 191-198.
  15. Merz AA, Cheng S. Sex differences in cardiovascular ageing. Heart. 2016; 102: 825-831.
  16. de Simone G, Devereux RB, Daniels SR, et al. Gender differences in left ventricular growth. Hypertension. 1995; 26: 979-983.
  17. Cheng S, Xanthakis V, Sullivan LM, et al. Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation. 2010; 122: 570-578.
  18. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol. 1993; 72: 310-313.
  19. Lieb W, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short-and long-term change in the framingham offspring study. Circulation. 2009; 119: 3085-3092.
  20. Gori M, Lam CS, Gupta DK, et al. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014; 16: 535-542.
  21. Yoneyama K, Gjesdal O, Choi EY, et al. Age, sex, and hypertension-related remodeling influences left ventricular torsion assessed by tagged cardiac magnetic resonance in asymptomatic individuals: the multi-ethnic study of atherosclerosis. Circulation. 2012; 126: 2481-2490.
  22. Hayward CS, Kelly RP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 1997; 30: 1863- 1871.
  23. Gerdts E, Okin PM, de Simone G, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008; 51: 1109-1114.
  24. Regitz-Zagrosek V, Kararigas G. Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol Rev. 2017; 97: 1-37.
  25. Bugiardini R, Bairey Merz CN. Angina with "normal" coronary arteries: a changing philosophy. JAMA. 2005; 293: 477-484.
  26. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009; 54: 1561-1575.
  27. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol. 2009; 54: 2366-2373.
  28. Atsma F, Bartelink ML, Grobbee DE, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta analysis. Menopause. 2006; 13: 265-279.
  29. Guillaume M, Lapidus L, Lambert A. Differences in associations of familial and nutritional factors with serum lipids between boys and girls: the Luxembourg Child Study. Am J Clin Nutr. 2000; 72: 384-388.
  30. Bohm B, Hartmann K, Buck M, et al. Sex differences of carotid intima media thickness in healthy children and adolescents. Atherosclerosis. 2009; 206: 458-463.
  31. Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol. 2006; 47: 1976-1983.
  32. Mikkola TS, Gissler M, Merikukka M, et al. Sex differences in age-related cardiovascular mortality. PLoS One. 2013; 8: e63347.
  33. Connelly PJ, Azizi Z, Alipour P, et al. The Importance of Gender to Understand Sex Differences in Cardiovascular Disease. Can J Cardiol. 2021; 37: 699-710.
  34. Tamaya T, Wada K, Nakagawa M, et al. Sexual dimorphism of binding sites of testosterone and dihydrotestosterone in rabbit model. Comp Biochem Physiol Comp Physiol. 1993; 105: 745- 749.
  35. Kim-Schulze S, McGowan KA, Hubchak SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996; 94: 1402-1407.
  36. Thompson J, Khalil RA. Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol. 2003; 30: 1-15.
  37. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004; 286: 233- 249.
  38. Vitale C, Fini M, Speziale G, et al. Gender differences in the cardiovascular effects of sex hormones. Fundam Clin Pharmacol. 2010; 24: 675-685.
  39. El Hajj MC, Ninh VK, El Hajj EC, et al. Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats. Am J Physiol Heart Circ Physiol. 2017; 312: 98-105.
  40. Ettinger B, Friedman GD, Bush T, et al. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996; 87: 6-12.
  41. Leblanc AJ, Chen B, Dougherty PJ, et al. Divergent effects of aging and sex on vasoconstriction to endothelin in coronary 19 arterioles. Microcirculation. 2013; 20: 365-376.
  42. Lam CS, McEntegart M, Claggett B, et al. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2015; 17: 301-312.
  43. Huang A, Sun D, Koller A, et al. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. American Journal of Physiology. 1997; 272: 1804-1809.
  44. Moien-Afshari F, Kenyon E, Choy JC, et al. Long term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats. Maturitas. 2003; 45: 213-223.
  45. Wang Y, Kanatsuka H, Akai K, et al. Effects of low doses of endothelin-1 on basal vascular tone and autoregulatory vasodilation in canine coronary microcirculation in vivo. Jpn Circ J. 1999; 63: 617-623.
  46. Berti F, Rossoni G, Della BD, et al. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J CardiovascPharmacol. 1993; 22: 321-326.
  47. Bird JE, Waldron TL, Dorso CR, et al. Effects of the endothelin (ET) receptor antagonist BQ 123 on initial and delayed vascular responses induced by ET-1 in conscious, normotensive rats. J CardiovascPharmacol. 1993; 22: 69-73.
  48. Brunner F, Bras-Silva C, Cerdeira AS, et al. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther. 2006; 111: 508-531.
  49. Kingma JG Jr, Laher I. Effect of endothelin on sex-dependent regulation of tone in coronary resistance vessels. Biochem Biophys Res Commun. 2021; 540: 56-60.
  50. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995; 92: 3431- 3435.
  51. DuPont JJ, Kim SK, Kenney RM, et al. Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor. Am J Physiol Heart Circ Physiol. 2021; 320: 169-180.
  52. Shipley RD, Muller-Delp JM. Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium- dependent mechanisms. Cardiovasc Res. 2005; 66: 374-383.
  53. Korzick DH, Muller-Delp JM, Dougherty P, et al. Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C. Cardiovasc Res. 2005; 66: 384-392.
  54. Kelly RF, Hursey TL, Schaer GL, et al. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. J Investig Med. 1996; 44: 575-582.
  55. Wellman GC, Bonev AD, Nelson MT, et al. Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca 2+ -dependent K + channels. Circulation Research. 1996; 79: 1024-1030.
  56. Wu Y, Huang A, Sun D, et al. Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation. Am J Physiol Heart Circ Physiol. 2001; 280: 2456- 2461.
  57. Fraccarollo D, Hu K, Galuppo P, et al. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation. 1997; 96: 3963-3973.
  58. Forte P, Kneale BJ, Milne E, et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension. 1998; 32: 730-734.
  59. Nguyen A, Thorin-Trescases N, Thorin E. Working under pressure: coronary arteries and the endothelin system. Am J Physiol Regul Integr Comp Physiol. 2010; 298: 1188-1194.
  60. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990; 85: 587-590.
  61. Mitsutomi N, Akashi C, Odagiri J, et al. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol. 1999; 364: 65-73.
  62. Warner TD. Relationships between the endothelin and nitric oxide pathways. Clin Exp Pharmacol Physiol. 1999; 26: 247- 252.
  63. Verma S, Skarsgard P, Bhanot S, et al. Reactivity of mesenteric arteries from fructose hypertensive rats to endothelin. Am J Hypertens. 1997; 10: 1010-1019.
  64. Flores-Monroy J, Ramirez-Hernandez D, Samano-Hernandez C, et al. Sex Differences in Vascular Reactivity to Angiotensin II During the Evolution of Myocardial Infarction. J Cardiovasc Pharmacol. 2018; 71: 19-25.
  65. Gardner JD, Brower GL, Voloshenyuk TG, et al. Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and 21 phytoestrogens. Am J Physiol Heart Circ Physiol. 2008; 294: 198-204.
  66. Kolodgie FD, Farb A, Litovsky SH, et al. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol. 1997; 29: 2403-2414.
  67. Sbarouni E, Iliodromitis EK, Bofilis E, et al. Short-term estrogen reduces myocardial infarct size in oophorectomized female rabbits in a dose-dependent manner. Cardiovasc Drugs Ther. 1998; 12: 457-462.
  68. Hale SL, Birnbaum Y, Kloner RA. B-estradiol, but not a-estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J. 1996; 132: 258-262.
  69. Kim YD, Chen B, Beauregard J, et al. 17 beta Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation. 1996; 94: 2901-2908.
  70. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332: 481-487.
  71. Rouleau JR, Dagnault A, Simard D, et al. Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits. Am J Physiol Heart Circ Physiol. 2001; 281: 1407-1412.
  72. Wilting J. Integrated vascular anatomy. Lanzer PT, E.J., editor. Berlin, Heidelberg: Springer. 2002.
  73. Bailey AL, Scantlebury DC, Smyth SS. Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol. 2009; 29: 284-288.
  74. Sheifer SE, Canos MR, Weinfurt KP, et al. Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J. 2000; 139: 649-653.
  75. Gilligan DM, Quyyumi AA, Cannon RO, 3rd. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994; 89: 2545-2551.
  76. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible?. J Am Coll Cardiol. 1997; 30: 325-333.
  77. Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res. 2002; 53: 597-604.
  78. Kardys I, Vliegenthart R, Oudkerk M, et al. The female advantage in cardiovascular disease: do vascular beds contribute equally?. Am J Epidemiol. 2007; 166: 403-412.
  79. Campbell DJ, Somaratne JB, Jenkins AJ, et al. Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease. Hypertension. 2011; 57: 186-192.
  80. von Mering GO, Arant CB, Wessel TR, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004; 109: 722-725.
  81. AlBadri A, Bairey Merz CN, Johnson BD, et al. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. J Am Coll Cardiol. 2019; 73: 684-693.
  82. Khuddus MA, Pepine CJ, Handberg EM, et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol. 2010; 23: 511-519.
  83. Braith RW, Conti CR, Nichols WW, et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham- controlled study. Circulation. 2010; 122: 1612-1620.
  84. Crandall CJ, Barrett-Connor E. Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review. Endocrinol Metab Clin North Am. 2013; 42: 227-253.
  85. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ. 1995; 311: 1193-1196.
  86. Nicolaou PA. Sex differences in heart failure medications targeting the renin angiotensin-aldosterone system. Eur J Pharmacol. 2021; 897: 173961.
  87. Coutinho T. Arterial stiffness and its clinical implications in women. Can J Cardiol. 2014; 30: 756-764.
  88. DuPont JJ, Kenney RM, Patel AR, et al. Sex differences in mechanisms of arterial stiffness. Br J Pharmacol. 2019; 176: 4208-4225.
  89. Keller KM, Howlett SE. Sex Differences in the Biology and Pathology of the Aging Heart. Can J Cardiol. 2016; 32: 1065- 1073.
  90. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003; 107: 139-146.
  91. Barnett SR, Morin RJ, Kiely DK, et al. Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension. 1999; 33: 1195-1200.
  92. Christou DD, Jones PP, Jordan J, et al. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation. 2005; 111: 494-498.
  93. Zaydun G, Tomiyama H, Hashimoto H, et al. Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. Atherosclerosis. 2006; 184: 137-42.
  94. Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992; 23: 1705-1711.
  95. Janowitz WR, Agatston AS, Kaplan G, et al. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol. 1993; 72: 247-254.
  96. Ota H, Reeves MJ, Zhu DC, et al. Sex differences in patients with asymptomatic carotid atherosclerotic plaque: in vivo 3.0-T magnetic resonance study. Stroke. 2010; 41: 1630-1635.
  97. Stehli J, Martin C, Brennan A, et al. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention. J Am Heart Assoc. 2019; 8: e012161. 124.
  98. Roswell RO, Kunkes J, Chen AY, et al. Impact of Sex and Contact-to-Device Time on Clinical Outcomes in Acute ST- Segment Elevation Myocardial Infarction-Findings From the National Cardiovascular Data Registry. J Am Heart Assoc. 2017; 6. 125. Sederholm Lawesson S, Isaksson RM, Ericsson M, et al. Gender disparities in first medical contact and delay in ST-elevation myocardial infarction: a prospective multicentre Swedish survey study. BMJ Open. 2018; 8: e020211. 126. Fu WX, Zhou TN, Wang XZ, et al. Sex-Related Differences in Short-and Long-Term Outcome among Young and Middle- Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention. Chin Med J (Engl). 2018; 131: 1420-1429. 127. Lidegaard O. Hormonal contraception, thrombosis and age. Expert Opin Drug Saf. 2014; 13: 1353-1360. 128. Li Y, Kloner RA. Is There a Gender Difference in Infarct Size and Arrhythmias Following Experimental Coronary Occlusion and Reperfusion?. J Thromb Thrombolysis. 1995; 2: 221-225. 129. Przyklenk K, Ovize M, Bauer B, et al. Gender does not influence acute myocardial infarction in adult dogs. Am Heart J. 1995; 129: 1108-1113. 130. Lee TM, Su SF, Tsai CC, et al. Cardioprotective effects of 17 beta estradiol produced by activation ofmitochondrial ATP- sensitive K(+)Channels in canine hearts. J Mol Cell Cardiol. 2000; 32: 1147-1158. 131. Brown DA, Lynch JM, Armstrong CJ, et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol. 2005; 564: 619-630. 132. Turcato S, Turnbull L, Wang GY, et al. Ischemic preconditioning depends on age and gender. Basic Res Cardiol. 2006; 101: 235- 243. 133. Humphreys RA, Kane KA, Parratt JR. The influence of maturation and gender on the anti-arrhythmic effect of ischaemic preconditioning in rats. Basic Res Cardiol. 1999; 94: 1-8. 134.
  99. Song X, Li G, Vaage J, et al. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand. 2003; 177: 459-466. 135. Wang M, Baker L, Tsai BM, et al. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab. 2005; 288: 321-326. 136. Dougherty CJ, Kubasiak LA, Prentice H, et al. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J. 2002; 362: 561-571. 137. Salituro FG, Germann UA, Wilson KP, et al. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases. Curr Med Chem. 1999; 6: 807-823. 138. Murry CE, Jennings RB, Reimer KA. Preconditioning with © 2022 Dioum M, et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ischemia: a delay of lethal cell injury in ischemic myocardium. Circ. 1986; 74: 1124-1136. 139. Brown DA, Jew KN, Sparagna GC, et al. Exercise training preserves coronary flow and reduces infarct size after ischemia- reperfusion in rat heart. J Appl Physiol (1985). 2003; 95: 2510- 2518. 140. Yamashita N, Baxter GF, Yellon DM. Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanism. Heart. 2001; 85: 331-336. 141. Hamilton KL, Staib JL, Phillips T, et al. Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion. Free Radic Biol Med. 2003; 34: 800-809. 142. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 2013; 381: 166-175. 143. Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res. 2006; 70: 297-307. 144. Penna C, Tullio F, Merlino A, et al. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol. 2009; 104: 390-402. 145. Ciocci Pardo A, Scuri S, Gonzalez Arbelaez LF, et al. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning. Cardiovasc Pathol. 2018; 33: 19-26. 146. Litwin SE, Katz SE, Litwin CM, et al. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999; 91: 173-183. 147. Lieder HR, Irmert A, Kamler M, et al. Sex is no determinant of cardioprotection by ischemic preconditioning in rats, but ischemic/reperfused tissue mass is for remote ischemic preconditioning. Physiol Rep. 2019; 7: e14146. 148. Kleinbongard P, Neuhauser M, Thielmann M, et al. Confounders of Cardioprotection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting. Cardiology. 2016; 133: 128-133. 149. Crimi G, Pica S, Raineri C, et al. Remote ischemic post- conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv. 2013; 6: 1055-1063. 150. Sloth AD, Schmidt MR, Munk K, et al. Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: post hoc subgroup analysis of a randomised controlled trial. BMJ Open. 2015; 5: e006923. 151. Eitel I, Stiermaier T, Rommel KP, et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur Heart J. 2015; 36: 3049-3057.

Cited by

Metadata

Authors
Kingma Jr, J. G.
Venue
Cardiology & Vascular Research
Publisher
SciVision Publishers LLC
Published
2022-02-25
Volume
6
Issue
1
ISSN
2639-8486
DOI
10.33425/2639-8486.1134
Cited by
2
References
2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.